Genomics, Cancer Care and Advocacy
by S.F. Terry, K. Zeitz, M.A. Majumder, P.F. Terry
Publisher: Genetic Alliance 2006
Number of pages: 29
In the past several decades, oncologists and cancer researchers have come to recognize the importance of the role of advocacy organizations in cancer research and treatment. With genomics poised to become a major force in cancer care, advocacy organizations have an important role to play in traditional areas of concern such as patient education about new genomic technologies.
Home page url
Download or read it online for free here:
by Paul J. Grippo, Hidayatullah G. Munshi - Transworld Research Network
Pancreatic adenocarcinoma is histologically characterized by a dense desmoplastic reaction surrounding malignant epithelial cells. The DR is composed of ECM proteins, fibroblasts, stellate cells, endothelial cells, immune cells, and neurons.
by Jianyuan Chai (ed.) - InTech
Angiogenesis is an extension process of the cardiovascular network. It is usually triggered by the demand of oxygen and nutrients from the fast growing tissue and uncontrollably dividing cells, as seen during wound healing and tumor progression.
- International Agency for Research on Cancer
This volume Evaluates the carcinogenic risk to humans posed by infection with three schistosoma trematodes, three liver flukes and Helicobacter pylori, selected on the basis of a causal association between infection and the development of cancers.
- National Collaborating Centre for Cancer
These guidelines have been developed to help all those involved in the management of advanced breast cancer. The authors have tried to concentrate on those areas where it was felt uncertainty or practice variation currently exists.